CIK 0001604821
- Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010894487
- Phone
- +1 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-29 | Chapman Steven Leonard CEO AND PRESIDENT | Sale | −14,813 | $65.09 | $964K | 246,957 |
| 2024-01-29 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale | −3,426 | $65.09 | $223K | 194,977 |
| 2024-01-29 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale | −2,358 | $65.09 | $153K | 108,494 |
| 2024-01-26 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Grant or award | +68,976 | 1,072,556 | ||
| 2024-01-26 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Grant or award | +31,352 | 96,162 | ||
| 2024-01-26 | Sheena Jonathan Director | Grant or award | +9,405 | 479,131 | ||
| 2024-01-26 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Grant or award | +27,433 | 208,483 | ||
| 2024-01-26 | Chapman Steven Leonard CEO AND PRESIDENT | Grant or award | +86,220 | 261,770 | ||
| 2024-01-26 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Grant or award | +31,352 | 198,403 | ||
| 2024-01-26 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Grant or award | +31,352 | 110,852 | ||
| 2024-01-26 | ROSENMAN HERM Director | Grant or award | +303 | $63.79 | $19K | 61,685 |
| 2024-01-26 | HEALY JAMES Director | Grant or award | +264 | $63.79 | $17K | 42,500 |
| 2024-01-26 | BOTHA ROELOF Director | Grant or award | +352 | $63.79 | $22K | 352 |
| 2024-01-26 | Baynes Roy D. Director | Grant or award | +215 | $63.79 | $14K | 12,407 |
| 2024-01-24 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −944 | $67.00 | $63K | 64,810 |
| 2024-01-23 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −306 | $66.81 | $20K | 67,650 |
| 2024-01-23 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,896 | $65.70 | $125K | 65,754 |
| 2024-01-22 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +1,250 | 68,727 | ||
| 2024-01-22 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −771 | $68.16 | $53K | 67,956 |
| 2024-01-22 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,250 | 8,750 |
Page 81 of 85 · 1,682 trades